Life Science Tools Market Size To Reach $401.01 Billion By 2033

September 2025 | Report Format: Electronic (PDF)

Life Science Tools Market Growth & Trends

The global life science tools market size is anticipated to reach USD 401.01 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.21% from 2025 to 2033. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the ‘4D Nucleome Program’, which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Key players are also contributing to the growth of the market by providing advanced tools and techniques. Furthermore, companies are introducing new automated solutions in the market, which, in turn, provide lucrative opportunities for market growth. For instance, in February 2022, Covaris, LLC. announced the launch of truXTRAC FFPE Total NA Auto 96 Kit, a fully automated workflow comprising all necessary accessories, consumables, and reagents. This automated kit is powered by Adaptive Focused Acoustics (AFA) technology that allows both purification and extraction of RNA & DNA for FFPE (formalin fixed paraffin embedded) samples in 5 hours. The introduction of innovative solutions is expected to drive the market in the near future.

key Request a free sample copy or view report summary: Life Science Tools Market Report

Life Science Tools Market Report Highlights

  • The cell biology technology segment held the largest revenue share of 32.93% in 2024. The genomic technology market segment is expected to grow at the fastest CAGR over the forecast period.

  • The cell culture systems and 3D cell culture segment held the largest revenue share of 16.48% in 2024. The next-generation sequencing segment is expected to grow at the fastest CAGR of 13.79% over the forecast period.

  • The healthcare segment held the largest life science market revenue share of 31.92% in 2024. The biopharmaceutical segment is expected to grow fastest throughout the forecast period.

  • North America dominated the life science tools industry with the largest revenue share of 42.56% in 2024. The life science tools market in Asia Pacific is expected to grow significantly during the forecast period.

Life Science Tools Market Segmentation

Grand View Research has segmented the global life science tools market report based on product & service, technology, end use, and region.

Life Science Tools Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

  • Cell Culture Systems & 3D Cell Culture

    • Instruments

    • Consumables

    • Cell & Tissue Culture Services

  • Liquid Chromatography

    • Instruments

    • Consumables

    • Services

  • Mass Spectrometry

    • Instruments

    • Consumables

    • Services

  • Flow Cytometry

    • Instruments

    • Consumables

    • Services

  • Cloning & Genome Engineering

    • Kits, Reagents, and Consumables

    • Services

  • Microscopy & Electron Microscopy

    • Instruments

    • Consumables

    • Services

  • Next Generation Sequencing

    • Instruments

    • Consumables

    • Services

  • PCR & qPCR

    • Instruments

    • Consumables

    • Services

  • Nucleic Acid Preparation

    • Instruments

    • Consumables

    • Services

  • Nucleic Acid Microarray

    • Instruments

    • Consumables

    • Services

  • Sanger Sequencing

    • Instruments

    • Consumables

    • Services

  • Transfection Devices & Gene Delivery Technologies

    • Equipment

    • Reagents

  • NMR

    • Instruments

    • Consumables

    • Services

  • Other Separation Technologies

    • Instruments

    • Consumables

    • Services

  • Other Products & Services

    • Antibodies

    • General Supplies

    • Others

      • Instruments

      • Consumables

      • Services

Life Science Tools Technology Outlook (Revenue, USD Million, 2021 - 2033)

  • Genomic Technology

  • Proteomics Technology

  • Cell Biology Technology

  • Other Analytical & Sample Preparation Technology

  • Lab Supplies & Technologies

Life Science Tools End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Government & Academic

  • Biopharmaceutical Company

  • Healthcare

  • Industrial Applications

  • Others

Life Science Tools Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Singapore

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List Of Key Players in the Life Science Tools Market

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • F. Hoffmann-La Roche Ltd.

  • Bio-Rad Laboratories, Inc.

  • Danaher Corporation

  • Illumina, Inc.

  • Thermo Fisher Scientific, Inc.

  • QIAGEN N.V.

  • Merck KGaA

  • Shimadzu Corporation

  • Hitachi, Ltd.

  • Bruker Corporation

  • Oxford Instruments plc

  • Zeiss International

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization